OKUR OnKure Therapeutics, Inc.: institutional ownership and insider trading
76 funds reported holding $161M of OnKure Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $33.5M, with 31 new positions and 7 funds selling out; over the last 12 months insiders bought $0 and sold $5.63K on the open market.
Famous investors holding OKUR
- Ken Griffin (Citadel Advisors): $5.41M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.64M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $496K, 0.0% of the portfolio
Largest institutional holders of OKUR
- RA CAPITAL MANAGEMENT, L.P. — $18.2M
- BVF INC/IL — $14.8M
- ACORN CAPITAL ADVISORS, LLC — $12.9M
- StepStone Group LP — $12.1M
- ADAR1 Capital Management, LLC — $10.2M
- Vivo Capital, LLC — $8.79M
- Vestal Point Capital, LP — $8.33M
- BlackRock, Inc. (BLK) — $6.84M
- Trails Edge Capital Partners, LP — $6.56M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.55M
Recent OKUR insider trades
- Sep 21, 2026: Saccomano Nicholas A sold 87 shares ($258)
- Sep 21, 2026: Leverone Jason A. sold 302 shares ($897)
- Jun 22, 2026: Saccomano Nicholas A sold 86 shares ($378)
- Jun 22, 2026: Leverone Jason A. sold 303 shares ($1.33K)
5%+ owners
- AI Biotechnology LLC: 20.0% (Schedule 13D, filed Apr 7, 2026)
- RA Capital Management, L.P.: 9.9% (Schedule 13G, filed Apr 7, 2026)
- Anders Hove: 9.5% (Schedule 13G, filed Apr 1, 2026)
- BVF PARTNERS L P/IL: 8.0% (Schedule 13G/A, filed Aug 14, 2026)
- Coastlands Capital LP: 6.7% (Schedule 13G, filed Oct 7, 2026)
- StepStone Group LP: 6.6% (Schedule 13G, filed Apr 7, 2026)